www.fdanews.com/articles/200392-paige-receives-ce-marks-for-cancer-diagnostic-software
Paige Receives CE Marks for Cancer Diagnostic Software
December 10, 2020
Paige has been granted CE marks for its breast cancer detection software and prostate cancer grading solution, allowing their use in European laboratories and hospitals.
The company’s Paige Breast software identifies suspicious areas in breast biopsies for further review, pointing out concerning features on breast-tissue slides.
Paige’s Prostate Grading and Quantification diagnostic assists pathologists in assigning grades to cancerous prostate tissue.